» Articles » PMID: 31491949

Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Sep 8
PMID 31491949
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity characterized by adiposity and ectopic fat accumulation is associated with the development of non-alcoholic fatty liver disease (NAFLD). Treatments that stimulate lipid utilization may prevent the development of obesity and comorbidities. This study evaluated the potential anti-obesogenic hepatoprotective effects of combined treatment with L-carnitine and nicotinamide riboside, i.e., components that can enhance fatty acid transfer across the inner mitochondrial membrane and increase nicotinamide adenine nucleotide (NAD+) levels, which are necessary for β-oxidation and the TCA cycle, respectively. Ldlr -/-.Leiden mice were treated with high-fat diet (HFD) supplemented with L-carnitine (LC; 0.4% /), nicotinamide riboside (NR; 0.3% /) or both (COMBI) for 21 weeks. L-carnitine plasma levels were reduced by HFD and normalized by LC. NR supplementation raised its plasma metabolite levels demonstrating effective delivery. Although food intake and ambulatory activity were comparable in all groups, COMBI treatment significantly attenuated HFD-induced body weight gain, fat mass gain (-17%) and hepatic steatosis (-22%). Also, NR and COMBI reduced hepatic 4-hydroxynonenal adducts. Upstream-regulator gene analysis demonstrated that COMBI reversed detrimental effects of HFD on liver metabolism pathways and associated regulators, e.g., ACOX, SCAP, SREBF, PPARGC1B, and INSR. Combination treatment with LC and NR exerts protective effects on metabolic pathways and constitutes a new approach to attenuate HFD-induced obesity and NAFLD.

Citing Articles

Integrated metabolome and transcriptome analysis reveals key genes and pathways associated with egg yolk percentage in chicken.

Li W, Luo Y, Zhu S, Wang M, Zhao X, Ning Z Poult Sci. 2025; 104(3):104815.

PMID: 39914020 PMC: 11848451. DOI: 10.1016/j.psj.2025.104815.


Evaluating the causal relationship of Levo-carnitine and risk of schizophrenia: a bidirectional two-sample mendelian randomization study.

Qiu H, Zhong Z, Wu T, Hu H, Zhou M, Feng Z BMC Psychiatry. 2024; 24(1):720.

PMID: 39438849 PMC: 11515733. DOI: 10.1186/s12888-024-06177-1.


Metabolic dysfunction-associated steatotic liver disease is associated with effects on cerebral perfusion and white matter integrity.

Seidel F, Vreeken D, Custers E, Wiesmann M, Ozsezen S, van Duyvenvoorde W Heliyon. 2024; 10(19):e38516.

PMID: 39391513 PMC: 11466594. DOI: 10.1016/j.heliyon.2024.e38516.


Nicotinamide Riboside, a Promising Vitamin B Derivative for Healthy Aging and Longevity: Current Research and Perspectives.

Bita A, Scorei I, Ciocilteu M, Nicolaescu O, Pirvu A, Bejenaru L Molecules. 2023; 28(16).

PMID: 37630330 PMC: 10459282. DOI: 10.3390/molecules28166078.


Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.

Seidel F, Fluiter K, Kleemann R, Worms N, van Nieuwkoop A, Caspers M Front Cell Neurosci. 2023; 17:1205261.

PMID: 37457817 PMC: 10346859. DOI: 10.3389/fncel.2023.1205261.


References
1.
Dollerup O, Christensen B, Svart M, Schmidt M, Sulek K, Ringgaard S . A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018; 108(2):343-353. DOI: 10.1093/ajcn/nqy132. View

2.
Noland R, Koves T, Seiler S, Lum H, Lust R, Ilkayeva O . Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem. 2009; 284(34):22840-52. PMC: 2755692. DOI: 10.1074/jbc.M109.032888. View

3.
van Koppen A, Verschuren L, van den Hoek A, Verheij J, Morrison M, Li K . Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model. Cell Mol Gastroenterol Hepatol. 2017; 5(1):83-98.e10. PMC: 5738456. DOI: 10.1016/j.jcmgh.2017.10.001. View

4.
Shi W, Hegeman M, van Dartel D, Tang J, Suarez M, Swarts H . Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet. Mol Nutr Food Res. 2017; 61(8). PMC: 5573990. DOI: 10.1002/mnfr.201600878. View

5.
Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View